What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study
Main Authors: | Dean A Fergusson, Dar Dowlatshahi, Manoj M Lalu, Justin Presseau, Gisell Castillo, Madison Foster, Analyssa Cardenas, Whitney Tam, Jennifer Zlepnig, Deborah Timpson, Pascale Juneau |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/3/e034354.full |
Similar Items
-
Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study
by: Gisell Castillo, et al.
Published: (2021-03-01) -
Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol
by: Gisell Castillo, et al.
Published: (2021-03-01) -
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials
by: Madison Foster, et al.
Published: (2020-10-01) -
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
by: Gauruv Bose, et al.
Published: (2019-04-01) -
Third-Party Effects in Stakeholder Interviews
by: Melissa Beresford, et al.
Published: (2020-12-01)